NBIX Shares Outstanding History
Below is a table of the NBIX shares outstanding history going back to 1/29/2010:

Date NBIX Shares Outstanding
1/29/201044.06M
4/26/201054.83M
7/23/201054.84M
10/25/201054.86M
2/1/201154.89M
4/29/201155.20M
7/22/201155.24M
10/26/201155.26M
1/31/201266.24M
4/27/201266.31M
7/24/201266.33M
10/25/201266.38M
1/31/201366.51M
4/26/201366.73M
7/19/201367.06M
10/23/201367.34M
1/24/201467.79M
4/25/201475.86M
7/31/201475.92M
10/27/201476.01M
1/26/201577.16M
4/24/201585.42M
7/24/201585.87M
10/23/201586.20M
2/1/201686.45M
4/29/201686.66M
7/28/201686.75M
10/27/201686.87M
2/1/201787.11M
5/3/201788.07M
7/27/201788.22M
10/27/201788.49M
2/2/201889.27M
4/25/201889.90M
7/25/201890.47M
10/30/201890.68M
2/1/201990.82M
4/24/201991.29M
7/24/201991.58M
10/29/201992.09M
1/31/202092.29M
4/30/202092.87M
7/28/202093.25M
11/4/202093.43M
1/29/202193.94M
4/29/202194.55M

Also see: NBIX Market Cap History
NBIX YTD Return
NBIX Historical Shares Outstanding:
+7.02% CAGR
NBIX Historical Shares Outstanding: +7.02% CAGR

Mouse over chart for data details
1/29/2010 ...4/29/2021
Neurocrine Biosciences is a commercial-stage biopharmaceutical company focused on discovering and developing treatments for patients with neurological, endocrine and psychiatric disorders. Co. is primarily focused on the commercialization of INGREZZA® (valbenazine) in the United States. Co.'s late-stage pipeline includes opicapone as an adjunctive therapy to levodopa/DOPA decarboxylase inhibitors in adult Parkinson's disease patients, elagolix for the treatment of heavy menstrual bleeding associated with uterine fibroids in women, valbenazine for the treatment of chorea in adult patients with Huntington's disease and NBIb-1817 (VY-AADC) for the treatment of Parkinson's disease patients. We show 46 historical shares outstanding datapoints in our coverage of NBIX's shares outstanding history.

Understanding the changing numbers of NBIX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NBIX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NBIX by allowing them to research NBIX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for NBIX:
NBIX SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Neurocrine Biosciences (NBIX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NDRA Shares Outstanding History
NEO Shares Outstanding History
NEOG Shares Outstanding History
NEOS Shares Outstanding History
NERV Shares Outstanding History
NK Shares Outstanding History
NKTR Shares Outstanding History
NLNK Shares Outstanding History
NOVN Shares Outstanding History
NSPR Shares Outstanding History
More Healthcare companies »

 

NBIX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.